Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
10: STEP THERAPY NOT FOLLOWED An insurance payer may require the use of a preferred drug for intravitreal injections, typically a lower-cost medication such as bevacizumab, before initiating treatment with a higher-cost drug such as aflibercept
Decrease dose if: Experiencing consistent side effects (headaches, fatigue, GI disturbance), achieving satisfactory results at current dose with no need for escalation, or cost considerations favor using minimum effective dose
His goal is to foster healthier lifestyles to improve individuals quality of life and health span through online medical and non-medical services
Food and Drug Administration (2024) 2
Body Weight Body weight is irrelevant as it pertains to topical AHK-Cu dosing
Simply resume normal dosing at your next scheduled administration
